Results 31 to 40 of about 2,565 (197)
Pertactin-deficient isolates: evidence of increased circulation in Europe, 1998 to 2015. [PDF]
IntroductionPertussis outbreaks have occurred in several industrialised countries using acellular pertussis vaccines (ACVs) since the 1990s.
Berbers, Guy +19 more
core +7 more sources
Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013–2017
During the 2008–2012 pertussis epidemic in Australia, pertactin (Prn)–negative Bordetella pertussis emerged. We analyzed 78 isolates from the 2013–2017 epidemic and documented continued expansion of Prn-negative ptxP3 B. pertussis strains.
Zheng Xu +9 more
doaj +5 more sources
P30, the 32 kDa transmembrane C-terminal domain of pertactin from Bordetella pertussis, is supposed to form a β-barrel inserted into the outer membrane for the translocation of the passenger domain.
Yanshi Zhu +3 more
openalex +3 more sources
Structure of Bordetella pertussis virulence factor P.69 pertactin
A new generation of whooping-cough vaccines contain P.69 pertactin, a surface-exposed domain of an outer membrane protein expressed by the virulent bacterium Bordetella pertussis.
Paul Emsley +11 more
core +3 more sources
Pertactin-Negative Variants of Bordetella pertussis in the United States [PDF]
In 12 B. pertussis isolates from children in Philadelphia, 11 were negative for the pertactin antigen that is a component of the acellular vaccine. Such variants may reflect selection pressure from the vaccine and may reduce its effectiveness for preventing whooping cough.
Anne Marie Queenan +2 more
openalex +4 more sources
Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, France
Bordetella pertussis isolates that do not express pertactin (PRN) are increasing in regions where acellular pertussis vaccines have been used for >7 years. We analyzed data from France and compared clinical symptoms among infants
Hélène Bodilis, Nicole Guiso
doaj +2 more sources
Virulence of Pertactin-NegativeBordetella pertussisIsolates from Infants, France [PDF]
Bordetella pertussis isolates that do not express pertactin (PRN) are increasing in regions where acellular pertussis vaccines have been used for >7 years. We analyzed data from France and compared clinical symptoms among infants
Hélène Bodilis, Nicole Guiso
openalex +4 more sources
Recently, eight allelic variants of the pertactin gene (prn1-8) have been characterized in Bordetella pertussis strains isolated in Europe and the United States.
Johanna Mäkinen +4 more
doaj +2 more sources
Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis [PDF]
Recent reemergence of pertussis (whooping cough) in highly vaccinated populations and rapid expansion of Bordetella pertussis strains lacking pertactin (PRN), a common acellular vaccine antigen, have raised the specter of vaccine-driven evolution and ...
Longhuan Ma +3 more
doaj +3 more sources

